Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice

被引:46
作者
Jauch, Dominik [1 ]
Martin, Maria [1 ]
Schiechl, Gabriela [1 ]
Kesselring, Rebecca [1 ]
Schlitt, Hans Juergen [1 ]
Geissler, Edward K. [1 ]
Fichtner-Feigl, Stefan [1 ]
机构
[1] Univ Med Ctr Regensburg, Dept Surg, Regensburg, Germany
关键词
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; T-CELLS; COLORECTAL-CANCER; IFN-GAMMA; IL-21; DIFFERENTIATION; INDUCTION; PROMOTES; SURVIVAL;
D O I
10.1136/gutjnl-2011-300612
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims Colitis-associated tumorigenesis is a balance between proliferation of tumour cells and tumour immunosurveillance. The role of T-helper-cell-derived cytokines in tumour growth is not fully understood. In this study the authors investigated the influence of interleukin (IL) 21 on intestinal tumorigenesis. Methods Chronic colitis was induced in IL-21(-/-) and littermate control wild-type mice with three cycles of 1.5% dextran sulphate sodium (DSS) over 7 days followed by 7 days of drinking water. Mice received an azoxymethane injection on day 0 of DSS-colitis to induce tumorigenesis. Immunohistochemistry was performed on inflamed and tumour-bearing areas of colons. Cytokine expression of isolated colonic CD4 T cells was determined by ELISA. Cytotoxic capacity of isolated colonic CD8 T cells targeting tumour cells was evaluated by flow cytometry and quantitative cytotoxicity assay. Apoptosis of tumour cells was determined by TUNEL assay of colonic sections. Results Increasing expression of IL-21 was observed in chronic colitis, which showed functional importance, since IL-21 deficiency prevented chronic DSS-colitis development. Further, in the absence of IL-21, significantly fewer tumour nodules were detected, despite a similar extent of intestinal inflammation. In wild-type mice, 8.6 +/- 1.9 tumour nodules were found compared with 1.0 +/- 1.2 in IL-21-deficient mice. In tumour-bearing IL-21-deficient mice, intestinal inflammation was restored and partly dependent on interferon (IFN)-gamma, whereas the inflammation in wild-type mice showed high IL-17A concentrations. In these rare tumours in IL-21-deficient mice, tumour cell proliferation (Ki-67) was decreased, while cell apoptosis was increased, compared with wild-type mice. Increased IFN gamma expression in tumour-bearing IL-21-deficient mice led to increased tumour immunosurveillance mediated by cytotoxic CD8CD103 T cells targeting E-cadherin(+) colonic tumour cells and therefore limited tumour growth. Conclusion These results indicate that IL-21 orchestrates colitis-associated tumorigenesis, leading to the hypothesis that high IFN gamma and low IL-17A expression reduces tumour cell proliferation and increases tumour immunosurveillance.
引用
收藏
页码:1678 / 1686
页数:9
相关论文
共 47 条
  • [1] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [2] Issues in T-helper 1 development - resolved and unresolved
    Berenson, LS
    Ota, N
    Murphy, KM
    [J]. IMMUNOLOGICAL REVIEWS, 2004, 202 : 157 - 174
  • [3] gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
    Bollrath, Julia
    Phesse, Toby J.
    von Burstin, Vivian A.
    Putoczki, Tracy
    Bennecke, Moritz
    Bateman, Trudie
    Nebelsiek, Tim
    Lundgren-May, Therese
    Canli, Oezge
    Schwitalla, Sarah
    Matthews, Vance
    Schmid, Roland M.
    Kirchner, Thomas
    Arkan, Melek C.
    Ernst, Matthias
    Greten, Florian R.
    [J]. CANCER CELL, 2009, 15 (02) : 91 - 102
  • [4] The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
    Charles, Kellie A.
    Kulbe, Hagen
    Soper, Robin
    Escorcio-Correia, Monica
    Lawrence, Toby
    Schultheis, Anne
    Chakravarty, Probir
    Thompson, Richard G.
    Kollias, George
    Smyth, John F.
    Balkwill, Frances R.
    Hagemann, Thorsten
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) : 3011 - 3023
  • [5] The immunobiology of cancer immunosurveillance and immunoediting
    Dunn, GP
    Old, LJ
    Schreiber, RD
    [J]. IMMUNITY, 2004, 21 (02) : 137 - 148
  • [6] The risk of colorectal cancer in ulcerative colitis: a meta-analysis
    Eaden, JA
    Abrams, KR
    Mayberry, JF
    [J]. GUT, 2001, 48 (04) : 526 - 535
  • [7] IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells
    Fantini, Massimo C.
    Rizzo, Agelamaria
    Final, Daniele
    Caruso, Roberta
    Becker, Christoph
    Neurath, Markus F.
    MacDonald, Thomas T.
    Pallone, Francesco
    Monteleone, Giovanni
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (11) : 3155 - 3163
  • [8] Estimates of the cancer incidence and mortality in Europe in 2006
    Ferlay, J.
    Autier, P.
    Boniol, M.
    Heanue, M.
    Colombet, M.
    Boyle, P.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (03) : 581 - 592
  • [9] Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides
    Fichtner-Feigl, S
    Fuss, IJ
    Preiss, JC
    Strober, W
    Kitani, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) : 3057 - 3071
  • [10] Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-α2
    Fichtner-Feigl, Stefan
    Terabe, Masaki
    Kitani, Atsushi
    Young, Cheryl A.
    Fuss, Ivan
    Geissler, Edward K.
    Schlitt, Hans-Juergen
    Berzofsky, Jay A.
    Strober, Warren
    [J]. CANCER RESEARCH, 2008, 68 (09) : 3467 - 3475